nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Fluorouracil—head and neck cancer	0.552	1	CbGbCtD
Oseltamivir—Enterocolitis haemorrhagic—Vinblastine—head and neck cancer	0.0534	0.163	CcSEcCtD
Oseltamivir—CES1—larynx—head and neck cancer	0.0186	0.231	CbGeAlD
Oseltamivir—Angina unstable—Docetaxel—head and neck cancer	0.0105	0.0322	CcSEcCtD
Oseltamivir—NEU1—parotid gland—head and neck cancer	0.00996	0.124	CbGeAlD
Oseltamivir—NEU1—saliva-secreting gland—head and neck cancer	0.00954	0.119	CbGeAlD
Oseltamivir—NEU1—trachea—head and neck cancer	0.00736	0.0918	CbGeAlD
Oseltamivir—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00662	0.0203	CcSEcCtD
Oseltamivir—NEU1—thyroid gland—head and neck cancer	0.00582	0.0726	CbGeAlD
Oseltamivir—Encephalopathy—Fluorouracil—head and neck cancer	0.00573	0.0175	CcSEcCtD
Oseltamivir—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00541	0.0165	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00511	0.123	CbGpPWpGaD
Oseltamivir—CES1—neck—head and neck cancer	0.00492	0.0613	CbGeAlD
Oseltamivir—Foetor hepaticus—Docetaxel—head and neck cancer	0.00468	0.0143	CcSEcCtD
Oseltamivir—Hepatic failure—Hydroxyurea—head and neck cancer	0.00413	0.0126	CcSEcCtD
Oseltamivir—Herpes simplex—Fluorouracil—head and neck cancer	0.00399	0.0122	CcSEcCtD
Oseltamivir—Liver disorder—Docetaxel—head and neck cancer	0.0039	0.0119	CcSEcCtD
Oseltamivir—Throat sore—Docetaxel—head and neck cancer	0.00369	0.0113	CcSEcCtD
Oseltamivir—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00365	0.0112	CcSEcCtD
Oseltamivir—NEU1—lymph node—head and neck cancer	0.00362	0.0451	CbGeAlD
Oseltamivir—Dermatitis atopic—Docetaxel—head and neck cancer	0.00359	0.011	CcSEcCtD
Oseltamivir—Face oedema—Hydroxyurea—head and neck cancer	0.00358	0.011	CcSEcCtD
Oseltamivir—CES1—connective tissue—head and neck cancer	0.00353	0.044	CbGeAlD
Oseltamivir—Hepatotoxicity—Docetaxel—head and neck cancer	0.00344	0.0105	CcSEcCtD
Oseltamivir—Angina pectoris—Vinblastine—head and neck cancer	0.00343	0.0105	CcSEcCtD
Oseltamivir—Otitis media—Docetaxel—head and neck cancer	0.00341	0.0104	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00339	0.0819	CbGpPWpGaD
Oseltamivir—Rhinorrhoea—Docetaxel—head and neck cancer	0.00328	0.01	CcSEcCtD
Oseltamivir—SLC15A1—epithelium—head and neck cancer	0.00311	0.0387	CbGeAlD
Oseltamivir—Swelling—Fluorouracil—head and neck cancer	0.00303	0.00926	CcSEcCtD
Oseltamivir—Bone disorder—Docetaxel—head and neck cancer	0.00294	0.009	CcSEcCtD
Oseltamivir—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00292	0.00894	CcSEcCtD
Oseltamivir—Infestation NOS—Hydroxyurea—head and neck cancer	0.00286	0.00875	CcSEcCtD
Oseltamivir—Infestation—Hydroxyurea—head and neck cancer	0.00286	0.00875	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00276	0.0666	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0027	0.00827	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00267	0.00817	CcSEcCtD
Oseltamivir—Hepatocellular injury—Docetaxel—head and neck cancer	0.00266	0.00813	CcSEcCtD
Oseltamivir—Influenza like illness—Docetaxel—head and neck cancer	0.00258	0.00789	CcSEcCtD
Oseltamivir—CES1—lymphoid tissue—head and neck cancer	0.00258	0.0321	CbGeAlD
Oseltamivir—Hallucination—Hydroxyurea—head and neck cancer	0.00255	0.00781	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00241	0.0583	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CEBPA—head and neck cancer	0.00241	0.0582	CbGpPWpGaD
Oseltamivir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00239	0.00731	CcSEcCtD
Oseltamivir—CES1—thyroid gland—head and neck cancer	0.00234	0.0292	CbGeAlD
Oseltamivir—Anaemia—Vinblastine—head and neck cancer	0.00227	0.00693	CcSEcCtD
Oseltamivir—Angina pectoris—Fluorouracil—head and neck cancer	0.00225	0.00688	CcSEcCtD
Oseltamivir—Vertigo—Vinblastine—head and neck cancer	0.0022	0.00674	CcSEcCtD
Oseltamivir—Swelling—Docetaxel—head and neck cancer	0.00219	0.00669	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00215	0.00656	CcSEcCtD
Oseltamivir—Hepatic failure—Docetaxel—head and neck cancer	0.00215	0.00656	CcSEcCtD
Oseltamivir—Convulsion—Vinblastine—head and neck cancer	0.00212	0.0065	CcSEcCtD
Oseltamivir—CES1—head—head and neck cancer	0.00208	0.0259	CbGeAlD
Oseltamivir—Pneumonia—Fluorouracil—head and neck cancer	0.00207	0.00633	CcSEcCtD
Oseltamivir—Anaemia—Hydroxyurea—head and neck cancer	0.00207	0.00632	CcSEcCtD
Oseltamivir—Infestation NOS—Fluorouracil—head and neck cancer	0.00206	0.0063	CcSEcCtD
Oseltamivir—Infestation—Fluorouracil—head and neck cancer	0.00206	0.0063	CcSEcCtD
Oseltamivir—Visual disturbance—Docetaxel—head and neck cancer	0.00203	0.00622	CcSEcCtD
Oseltamivir—Conjunctivitis—Fluorouracil—head and neck cancer	0.002	0.00612	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—XRCC1—head and neck cancer	0.00197	0.0475	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Vinblastine—head and neck cancer	0.00196	0.00599	CcSEcCtD
Oseltamivir—Epistaxis—Fluorouracil—head and neck cancer	0.00194	0.00594	CcSEcCtD
Oseltamivir—Convulsion—Hydroxyurea—head and neck cancer	0.00194	0.00592	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00193	0.0467	CbGpPWpGaD
Oseltamivir—Sinusitis—Fluorouracil—head and neck cancer	0.00193	0.00591	CcSEcCtD
Oseltamivir—Pain in extremity—Docetaxel—head and neck cancer	0.00193	0.0059	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00193	0.0059	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00189	0.00578	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00183	0.0442	CbGpPWpGaD
Oseltamivir—Infection—Hydroxyurea—head and neck cancer	0.00181	0.00554	CcSEcCtD
Oseltamivir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00179	0.00547	CcSEcCtD
Oseltamivir—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00179	0.00546	CcSEcCtD
Oseltamivir—Liver function test abnormal—Docetaxel—head and neck cancer	0.00178	0.00545	CcSEcCtD
Oseltamivir—Skin disorder—Hydroxyurea—head and neck cancer	0.00177	0.00542	CcSEcCtD
Oseltamivir—Abdominal pain upper—Docetaxel—head and neck cancer	0.00176	0.00539	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00174	0.00531	CcSEcCtD
Oseltamivir—Nasopharyngitis—Docetaxel—head and neck cancer	0.00172	0.00527	CcSEcCtD
Oseltamivir—Pain—Vinblastine—head and neck cancer	0.00171	0.00523	CcSEcCtD
Oseltamivir—Arrhythmia—Fluorouracil—head and neck cancer	0.00165	0.00505	CcSEcCtD
Oseltamivir—Feeling abnormal—Vinblastine—head and neck cancer	0.00165	0.00504	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00164	0.005	CcSEcCtD
Oseltamivir—Angina pectoris—Docetaxel—head and neck cancer	0.00162	0.00497	CcSEcCtD
Oseltamivir—Dyspepsia—Hydroxyurea—head and neck cancer	0.00161	0.00491	CcSEcCtD
Oseltamivir—Abdominal pain—Vinblastine—head and neck cancer	0.00158	0.00484	CcSEcCtD
Oseltamivir—ABCC4—thyroid gland—head and neck cancer	0.00158	0.0196	CbGeAlD
Oseltamivir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00157	0.00482	CcSEcCtD
Oseltamivir—Fatigue—Hydroxyurea—head and neck cancer	0.00157	0.00481	CcSEcCtD
Oseltamivir—Pain—Hydroxyurea—head and neck cancer	0.00156	0.00477	CcSEcCtD
Oseltamivir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0015	0.0046	CcSEcCtD
Oseltamivir—Pneumonia—Docetaxel—head and neck cancer	0.00149	0.00457	CcSEcCtD
Oseltamivir—Anaemia—Fluorouracil—head and neck cancer	0.00149	0.00455	CcSEcCtD
Oseltamivir—Infestation—Docetaxel—head and neck cancer	0.00149	0.00455	CcSEcCtD
Oseltamivir—Infestation NOS—Docetaxel—head and neck cancer	0.00149	0.00455	CcSEcCtD
Oseltamivir—Hypersensitivity—Vinblastine—head and neck cancer	0.00147	0.00451	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00147	0.00451	CcSEcCtD
Oseltamivir—CES1—lymph node—head and neck cancer	0.00145	0.0181	CbGeAlD
Oseltamivir—Jaundice—Docetaxel—head and neck cancer	0.00145	0.00443	CcSEcCtD
Oseltamivir—Conjunctivitis—Docetaxel—head and neck cancer	0.00144	0.00442	CcSEcCtD
Oseltamivir—Body temperature increased—Hydroxyurea—head and neck cancer	0.00144	0.00441	CcSEcCtD
Oseltamivir—Asthenia—Vinblastine—head and neck cancer	0.00144	0.00439	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00141	0.0043	CcSEcCtD
Oseltamivir—Epistaxis—Docetaxel—head and neck cancer	0.0014	0.00429	CcSEcCtD
Oseltamivir—ABCC4—head—head and neck cancer	0.0014	0.0174	CbGeAlD
Oseltamivir—Convulsion—Fluorouracil—head and neck cancer	0.00139	0.00426	CcSEcCtD
Oseltamivir—SLC22A8—head—head and neck cancer	0.00139	0.0173	CbGeAlD
Oseltamivir—Myalgia—Fluorouracil—head and neck cancer	0.00137	0.00419	CcSEcCtD
Oseltamivir—Diarrhoea—Vinblastine—head and neck cancer	0.00137	0.00419	CcSEcCtD
Oseltamivir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00134	0.00411	CcSEcCtD
Oseltamivir—Hepatitis—Docetaxel—head and neck cancer	0.00133	0.00408	CcSEcCtD
Oseltamivir—Confusional state—Fluorouracil—head and neck cancer	0.00132	0.00405	CcSEcCtD
Oseltamivir—Dizziness—Vinblastine—head and neck cancer	0.00132	0.00405	CcSEcCtD
Oseltamivir—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00131	0.00402	CcSEcCtD
Oseltamivir—Asthenia—Hydroxyurea—head and neck cancer	0.00131	0.004	CcSEcCtD
Oseltamivir—Infection—Fluorouracil—head and neck cancer	0.0013	0.00399	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.0013	0.0315	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Fluorouracil—head and neck cancer	0.00129	0.00394	CcSEcCtD
Oseltamivir—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00129	0.00393	CcSEcCtD
Oseltamivir—Visual impairment—Docetaxel—head and neck cancer	0.00129	0.00393	CcSEcCtD
Oseltamivir—Vomiting—Vinblastine—head and neck cancer	0.00127	0.00389	CcSEcCtD
Oseltamivir—Erythema multiforme—Docetaxel—head and neck cancer	0.00126	0.00386	CcSEcCtD
Oseltamivir—Headache—Vinblastine—head and neck cancer	0.00125	0.00383	CcSEcCtD
Oseltamivir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00125	0.00382	CcSEcCtD
Oseltamivir—Eye disorder—Docetaxel—head and neck cancer	0.00125	0.00381	CcSEcCtD
Oseltamivir—Cardiac disorder—Docetaxel—head and neck cancer	0.00124	0.00379	CcSEcCtD
Oseltamivir—Dizziness—Hydroxyurea—head and neck cancer	0.00121	0.00369	CcSEcCtD
Oseltamivir—Immune system disorder—Docetaxel—head and neck cancer	0.0012	0.00369	CcSEcCtD
Oseltamivir—Mediastinal disorder—Docetaxel—head and neck cancer	0.0012	0.00368	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0012	0.00366	CcSEcCtD
Oseltamivir—Arrhythmia—Docetaxel—head and neck cancer	0.00119	0.00365	CcSEcCtD
Oseltamivir—Nausea—Vinblastine—head and neck cancer	0.00119	0.00363	CcSEcCtD
Oseltamivir—Insomnia—Fluorouracil—head and neck cancer	0.00119	0.00363	CcSEcCtD
Oseltamivir—Mental disorder—Docetaxel—head and neck cancer	0.00117	0.00357	CcSEcCtD
Oseltamivir—Vomiting—Hydroxyurea—head and neck cancer	0.00116	0.00355	CcSEcCtD
Oseltamivir—Dyspepsia—Fluorouracil—head and neck cancer	0.00116	0.00354	CcSEcCtD
Oseltamivir—Rash—Hydroxyurea—head and neck cancer	0.00115	0.00352	CcSEcCtD
Oseltamivir—Dermatitis—Hydroxyurea—head and neck cancer	0.00115	0.00351	CcSEcCtD
Oseltamivir—Headache—Hydroxyurea—head and neck cancer	0.00114	0.0035	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00113	0.00347	CcSEcCtD
Oseltamivir—Back pain—Docetaxel—head and neck cancer	0.00112	0.00344	CcSEcCtD
Oseltamivir—Pain—Fluorouracil—head and neck cancer	0.00112	0.00343	CcSEcCtD
Oseltamivir—Nausea—Hydroxyurea—head and neck cancer	0.00108	0.00331	CcSEcCtD
Oseltamivir—Feeling abnormal—Fluorouracil—head and neck cancer	0.00108	0.00331	CcSEcCtD
Oseltamivir—Anaemia—Docetaxel—head and neck cancer	0.00107	0.00328	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00104	0.0252	CbGpPWpGaD
Oseltamivir—Urticaria—Fluorouracil—head and neck cancer	0.00104	0.00319	CcSEcCtD
Oseltamivir—Body temperature increased—Fluorouracil—head and neck cancer	0.00104	0.00318	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—TYMS—head and neck cancer	0.00102	0.0247	CbGpPWpGaD
Oseltamivir—Cough—Docetaxel—head and neck cancer	0.00101	0.0031	CcSEcCtD
Oseltamivir—Convulsion—Docetaxel—head and neck cancer	0.00101	0.00308	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFA—head and neck cancer	0.001	0.0242	CbGpPWpGaD
Oseltamivir—Arthralgia—Docetaxel—head and neck cancer	0.000989	0.00302	CcSEcCtD
Oseltamivir—Myalgia—Docetaxel—head and neck cancer	0.000989	0.00302	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000982	0.003	CcSEcCtD
Oseltamivir—ABCC4—lymph node—head and neck cancer	0.000979	0.0122	CbGeAlD
Oseltamivir—Hypersensitivity—Fluorouracil—head and neck cancer	0.000967	0.00296	CcSEcCtD
Oseltamivir—Confusional state—Docetaxel—head and neck cancer	0.000956	0.00292	CcSEcCtD
Oseltamivir—NEU1—Metabolism—UROD—head and neck cancer	0.000952	0.023	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Docetaxel—head and neck cancer	0.000948	0.0029	CcSEcCtD
Oseltamivir—Infection—Docetaxel—head and neck cancer	0.000941	0.00288	CcSEcCtD
Oseltamivir—Nervous system disorder—Docetaxel—head and neck cancer	0.000929	0.00284	CcSEcCtD
Oseltamivir—Thrombocytopenia—Docetaxel—head and neck cancer	0.000928	0.00284	CcSEcCtD
Oseltamivir—Skin disorder—Docetaxel—head and neck cancer	0.00092	0.00282	CcSEcCtD
Oseltamivir—Diarrhoea—Fluorouracil—head and neck cancer	0.000898	0.00275	CcSEcCtD
Oseltamivir—Dizziness—Fluorouracil—head and neck cancer	0.000868	0.00266	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000863	0.00264	CcSEcCtD
Oseltamivir—Insomnia—Docetaxel—head and neck cancer	0.000857	0.00262	CcSEcCtD
Oseltamivir—Vomiting—Fluorouracil—head and neck cancer	0.000835	0.00255	CcSEcCtD
Oseltamivir—Dyspepsia—Docetaxel—head and neck cancer	0.000834	0.00255	CcSEcCtD
Oseltamivir—Rash—Fluorouracil—head and neck cancer	0.000828	0.00253	CcSEcCtD
Oseltamivir—Dermatitis—Fluorouracil—head and neck cancer	0.000827	0.00253	CcSEcCtD
Oseltamivir—Headache—Fluorouracil—head and neck cancer	0.000823	0.00252	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000818	0.0025	CcSEcCtD
Oseltamivir—Fatigue—Docetaxel—head and neck cancer	0.000817	0.0025	CcSEcCtD
Oseltamivir—Pain—Docetaxel—head and neck cancer	0.00081	0.00248	CcSEcCtD
Oseltamivir—Feeling abnormal—Docetaxel—head and neck cancer	0.000781	0.00239	CcSEcCtD
Oseltamivir—Nausea—Fluorouracil—head and neck cancer	0.00078	0.00239	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000775	0.00237	CcSEcCtD
Oseltamivir—Abdominal pain—Docetaxel—head and neck cancer	0.000749	0.00229	CcSEcCtD
Oseltamivir—Body temperature increased—Docetaxel—head and neck cancer	0.000749	0.00229	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—GRP—head and neck cancer	0.000743	0.0179	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000739	0.0178	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—UROD—head and neck cancer	0.000722	0.0174	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Docetaxel—head and neck cancer	0.000698	0.00214	CcSEcCtD
Oseltamivir—Asthenia—Docetaxel—head and neck cancer	0.00068	0.00208	CcSEcCtD
Oseltamivir—Diarrhoea—Docetaxel—head and neck cancer	0.000648	0.00198	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000641	0.0155	CbGpPWpGaD
Oseltamivir—Dizziness—Docetaxel—head and neck cancer	0.000627	0.00192	CcSEcCtD
Oseltamivir—Vomiting—Docetaxel—head and neck cancer	0.000603	0.00184	CcSEcCtD
Oseltamivir—Rash—Docetaxel—head and neck cancer	0.000598	0.00183	CcSEcCtD
Oseltamivir—Dermatitis—Docetaxel—head and neck cancer	0.000597	0.00183	CcSEcCtD
Oseltamivir—Headache—Docetaxel—head and neck cancer	0.000594	0.00182	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTM1—head and neck cancer	0.000582	0.014	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—GRP—head and neck cancer	0.000563	0.0136	CbGpPWpGaD
Oseltamivir—Nausea—Docetaxel—head and neck cancer	0.000563	0.00172	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00056	0.0135	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFA—head and neck cancer	0.000541	0.0131	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00042	0.0101	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000416	0.01	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NAT2—head and neck cancer	0.000395	0.00955	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—DPYD—head and neck cancer	0.000347	0.00837	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000346	0.00836	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—YAP1—head and neck cancer	0.000329	0.00795	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000318	0.00769	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000315	0.00761	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—head and neck cancer	0.000314	0.00758	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000302	0.0073	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NAT2—head and neck cancer	0.0003	0.00724	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000269	0.00649	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—DPYD—head and neck cancer	0.000263	0.00635	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000258	0.00622	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—YAP1—head and neck cancer	0.000249	0.00602	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000247	0.00597	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—head and neck cancer	0.000226	0.00545	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000216	0.00521	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000215	0.00519	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—TYMS—head and neck cancer	0.000198	0.00477	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—head and neck cancer	0.000195	0.00472	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000187	0.00452	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GPX1—head and neck cancer	0.000187	0.00452	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP1A1—head and neck cancer	0.000185	0.00447	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000163	0.00395	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000152	0.00367	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TYMS—head and neck cancer	0.00015	0.00362	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—head and neck cancer	0.000148	0.00357	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GPX1—head and neck cancer	0.000142	0.00342	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1A1—head and neck cancer	0.00014	0.00339	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000118	0.00284	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000115	0.00278	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—head and neck cancer	0.00011	0.00266	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.0001	0.00242	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—head and neck cancer	9.6e-05	0.00232	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	9.47e-05	0.00229	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	9.01e-05	0.00218	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—head and neck cancer	8.34e-05	0.00201	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	7.82e-05	0.00189	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—head and neck cancer	7.28e-05	0.00176	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—head and neck cancer	6.77e-05	0.00164	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	6.39e-05	0.00154	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—head and neck cancer	6.07e-05	0.00147	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—head and neck cancer	5.53e-05	0.00134	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—head and neck cancer	5.16e-05	0.00125	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—head and neck cancer	5.13e-05	0.00124	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MAPK3—head and neck cancer	4.88e-05	0.00118	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MAPK1—head and neck cancer	4.64e-05	0.00112	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—head and neck cancer	4.19e-05	0.00101	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—head and neck cancer	4.03e-05	0.000973	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—head and neck cancer	3.9e-05	0.000941	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—head and neck cancer	3.73e-05	0.0009	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—head and neck cancer	3.29e-05	0.000795	CbGpPWpGaD
